It was noted as the first , non-opioid drug approved in the US for the treatment of opioid withdrawal .
Lofexidine was first approved by the US FDA on May 16 , 2018 under the brand name Lucemyra , produced by US WorldMeds .
brand name was noted as the first , non-opioid drug approved in the US for the treatment of opioid withdrawal .
Lofexidine was first approved by the US FDA on May 16 , 2018 under the brand name Lucemyra , produced by US WorldMeds .